INTRODUCTION
Thyroid hormone plays a vital role in the normal development of the central nervous system. Deficiency of thyroid hormone is one of the most common causes of preventable mental retardation. Congenital hypothyroidism is defined as thyroid hormone deficiency at birth. Screening by blood spot TSH is one of the most recognised tools to diagnose congenital hypothyroidism. It is one of the most effective methods to prevent severe developmental and physical morbidity associated with congenital hypothyroidism. [1] [2] [3] [4] The clinical manifestations are often subtle and not evident at birth. Common symptoms include lethargy, temperature instability, feeding problems and prolonged jaundice. Hypothyroidism in newborn period is often missed in view of subtle manifestation which may lead on to delay in diagnosis and resulting mental retardation and growth failure. This emphasizes the importance neonatal screening for early diagnosis and management. Neonatal screening for congenital hypothyroidism should be done after 48 hours of age. Blood spot TSH or T4 or both can be used for screening for congenital hypothyroidism. Heel prick dry blot method of sample collection is proven to be more appropriate for mass screening. [5] [6] [7] In our community data on prevalence of congenital hypothyroidism is lacking. Therefore the study was planned to estimate the burden of congenital hypothyroidism. This would help in early detection and treat the potential congenital hypothyroid newborns to realize their neurological potential and growth thus reducing the morbidity of preventable mental retardation and growth failure.
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METHODS
This prospective cross sectional study was conducted in neonatal unit of RSRM Lying in hospital -Stanley medical college, Chennai, India from March to May 2012. The RSRM Lying in hospital is the obstetric and neonatal unit attached to government Stanley medical college hospital, Chennai in Tamilnadu which caters to the middle and lower income population with mother and neonatal care services.
All newborns with gestational age of 34 weeks or more delivered in the hospital were included in the study.
Preterm infants with gestational age less than 34 weeks, those who have received blood transfusion prior to sampling, neonates more than 7 days of age and refusal of informed consent were excluded from the study.
Sample was collected after getting informed consent after 48 hours of age till 7 days of age. Demographic data of gestational age, sex, birth weight was recorded. Maternal history of any thyroid disease and any anti thyroid drugs intake during pregnancy was recorded for accurate interpretation of our data.
1695 babies who met the inclusion criteria were enrolled in the study from which sample was collected by proper aseptic precautions. The blood sample was collected by heel prick on to a filter paper and TSH levels estimated by dissociation enhanced lanthanide fluorescent immunoassay (DELFIA). 5 New-borns that had a TSH value more than 20 µIU/L were labelled as a case of congenital hypothyroidism which was also confirmed by venous sample before treatment was started. Due to financial constraints only TSH estimation was done. The data of sex, age, birth weight and TSH values were analysed and tabulated.
RESULTS
The study population consists of 1695 newborns. Among the 1695 (100%) babies, 914 (53.9%) were male and 781 (46.1%) were female babies. Out of 1695 babies less than 2500 gm was 279 (16.5%) babies more than 2500 gm was 1416 (83.5%) babies. Among the 1695 babies less than 37 weeks of gestation was 107 (6.3%) and more than 37 weeks was 1588 (93.7%).
Among 1695 babies 3 (1.7 per 1000) babies were screen positive with level of above 20 µIU/L. About two babies were female and one male baby. All the three babies were more than 37 weeks also 2500 gm and above. In our study we had 914 male children (53.9%) and 781 female children (46.1%) ( Table 2 and Figure 1 ). Figure 2 ). The preterm babies were 107 (6.30%) and term babies were 1588 (93.70%) ( Table 4 and Figure 3 ). Since, the above data not followed normal distribution, we have done non parametric t test. There exists a statistical significance between pre term and term babies with respect to their TSH values (Table 6A-6C) . This clearly indicates, there is a need for universal screening TSH program that must be a mandatory to all new born. .011
Figure 1: Gender distribution
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Sensitivity and specificity
The whole point of an ROC curve is to help you decide where to draw the line between 'normal' and 'not normal'. It tabulates and plots the sensitivity and specificity of the test at various cut-off values. The optimal cutoff value will be shown in the graph.
Sensitivity:
The fraction of people with the disease that the test correctly identifies as positive.
Specificity:
The fraction of people without the disease that the test correctly identifies as negative. 
CONCLUSION
Our study results revealed the prevalence of congenital hypothyroidism among neonates is 1.7 per thousand. It correlated with a study by Sanghvi U (2.1 per thousand). This clearly indicates, there is a need for universal screening for Hypo thyroidism to be implemented regularly in all new borns.
